Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Response Aid is a Dubai-based joint venture focused on procuring, developing and commercializing diagnostic, protective and pharmaceutical products for COVID-19 and other public health threats, including an exclusive worldwide (ex-Japan/China/Russia) license with Dr. Reddy’s for the antiviral favipiravir (Avigan/reeqonus) and deployment of digital health tools such as the MUNA blockchain-based COVID-19 testing and vaccine certification system.[2][3][7][9]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global Response Aid.